We hypothesized that this might be related to the renin- and angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and statins taken by AF patients, which could reduce vascular oxidative stress and have vasoprotective effects (Förstermann and Sessa, 2012). Here, REN is linked to atrial fibrillation.